Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient

BACKGROUND: Temozolomide (TMZ) is safe and effective in the treatment of aggressive pituitary adenomas (PAs). However, the optimal duration of TMZ therapy is still unknown. Moreover, data about administration of TMZ in elderly (≥65 years) people to treat aggressive PAs are scarce. We report the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Decaroli, Maria Chiara, Ansaloni, Anna, Monzani, Maria Laura, Losa, Marco, Zunarelli, Elena, Rochira, Vincenzo, Madeo, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237844/
https://www.ncbi.nlm.nih.gov/pubmed/34195524
http://dx.doi.org/10.1210/jendso/bvab065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237844/
https://www.ncbi.nlm.nih.gov/pubmed/34195524
http://dx.doi.org/10.1210/jendso/bvab065

Ejemplares similares